Summary of Significant Accounting Policies (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
Supplemental Cash Flow Elements [Abstract] |
|
Summary of Subsidiaries |
The Company’s subsidiaries and its interests in each are presented below as of December 31, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MPX Bioceutical ULC (“MPX ULC”) (1)
|
|
Canada |
|
|
100 |
% |
|
|
Luxembourg |
|
|
100 |
% |
|
|
Arizona, USA |
|
|
100 |
% |
|
|
Arizona, USA |
|
|
100 |
% |
Health For Life, Inc. (1)
|
|
Arizona, USA |
|
|
100 |
% |
iAnthus Arizona, LLC (“iA AZ”) |
|
Arizona, USA |
|
|
100 |
% |
|
|
Arizona, USA |
|
|
100 |
% |
S8 Rental Services, LLC (1)
|
|
Arizona, USA |
|
|
100 |
% |
Soothing Options, Inc. (1)
|
|
Arizona, USA |
|
|
100 |
% |
The Healing Center Wellness Center, Inc. (“THCWC”) (1)
|
|
Arizona, USA |
|
|
100 |
% |
Bergamot Properties, LLC |
|
Colorado, USA |
|
|
100 |
% |
Scarlet Globemallow, LLC |
|
Colorado, USA |
|
|
100 |
% |
iAnthus Capital Management, LLC (“ICM”) |
|
Delaware, USA |
|
|
100 |
% |
GHHIA Management, Inc. (“GHHIA”) |
|
Florida, USA |
|
|
100 |
% |
GrowHealthy Properties, LLC (“GHP”) |
|
Florida, USA |
|
|
100 |
% |
iAnthus Holdings Florida, LLC (“IHF”) |
|
Florida, USA |
|
|
100 |
% |
McCrory’s Sunny Hill Nursery, LLC (“McCrory’s”) |
|
Florida, USA |
|
|
100 |
% |
iA IT, LLC |
|
Illinois, USA |
|
|
100 |
% |
|
|
Maryland, USA |
|
|
100 |
% |
GreenMart of Maryland, LLC (1)
|
|
Maryland, USA |
|
|
100 |
% |
LMS Wellness, Benefit, LLC (1)
|
|
Maryland, USA |
|
|
100 |
% |
Rosebud Organics, Inc. (1)
|
|
Maryland, USA |
|
|
100 |
% |
Cannatech Medicinals, Inc. (1)
|
|
Massachusetts, USA |
|
|
100 |
% |
Fall River Development Company, LLC (1)
|
|
Massachusetts, USA |
|
|
100 |
% |
|
|
Massachusetts, USA |
|
|
100 |
% |
Mayflower Medicinals, Inc. |
|
Massachusetts, USA |
|
|
100 |
% |
Pilgrim Rock Management, LLC |
|
Massachusetts, USA |
|
|
100 |
% |
CGX Life Sciences, Inc. (“CGX”) (1)
|
|
Nevada, USA |
|
|
100 |
% |
GreenMart of Nevada NLV, LLC (GMNV) (1)
|
|
Nevada, USA |
|
|
100 |
% |
iAnthus Northern Nevada, LLC |
|
Nevada, USA |
|
|
100 |
% |
GTL Holdings, LLC |
|
New Jersey, USA |
|
|
100 |
% |
iA CBD, LLC (“iA CBD”) |
|
New Jersey, USA |
|
|
100 |
% |
iAnthus New Jersey, LLC |
|
New Jersey, USA |
|
|
100 |
% |
|
|
New Jersey, USA |
|
|
100 |
% |
Citiva Medical, LLC (“Citiva”) |
|
New York, USA |
|
|
100 |
% |
iAnthus Empire Holdings, LLC |
|
New York, USA |
|
|
100 |
% |
|
|
Vermont, USA |
|
|
100 |
% |
Grassroots Vermont Management Services, LLC (2)
|
|
Vermont, USA |
|
|
100 |
% |
Pakalolo, LLC |
|
Vermont, USA |
|
|
100 |
% |
(1) |
Entities acquired as a part of the MPX Bioceutical Corporation (“MPX”) acquisition on February 5, 2019 (the “MPX Acquisition”). |
(2) |
Entities in Vermont - the sale agreement for the business in Vermont was executed on February 6, 2023. |
|
Summary of Cash And Cash Equivalents Restricted Cash And Restricted Cash Equivalents |
The following table summarizes a reconciliation of cash and restricted cash reported within the consolidated balance sheets to such amounts presented in the statements of cash flows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
$ |
14,336 |
|
|
$ |
13,244 |
|
Restricted cash |
|
|
70 |
|
|
|
3,334 |
|
|
|
|
|
|
|
|
|
|
Total cash and restricted cash presented in the statements of cash flows |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary of Property Plant And Equipment Useful Life |
Property, plant and equipment are recorded at historical cost net of accumulated depreciation, write-downs and impairment losses. Depreciation is calculated on a straight-line basis over the estimated useful life as follows:
|
|
|
|
|
Buildings |
|
— |
|
20 - 25 years |
|
|
|
Leasehold improvements |
|
— |
|
over the shorter of the initial term of the underlying lease plus any reasonably assured renewal terms, and the useful life of the asset |
|
|
|
Production equipment |
|
— |
|
5 years |
|
|
|
Processing equipment |
|
— |
|
5 years |
|
|
|
Sales equipment |
|
— |
|
3 - 5 years |
|
|
|
Office equipment |
|
— |
|
3 - 5 years |
|
|
|
Land |
|
— |
|
not depreciated |
|
Summary of Effects Of the Adjustment On The Line items Within Consolidated Financial Statements |
The effect of the adjustments on the line items within the Company’s consolidated balance sheet as of December 31, 2021 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventories |
|
$ |
30,447 |
|
|
$ |
(1,755 |
) |
|
$ |
28,692 |
|
Current assets |
|
|
55,401 |
|
|
|
(1,755 |
) |
|
|
53,646 |
|
Total assets |
|
|
346,744 |
|
|
|
(1,755 |
) |
|
|
344,989 |
|
Accrued and other current liabilities |
|
|
99,446 |
|
|
|
(513 |
) |
|
|
98,933 |
|
Current liabilities |
|
|
285,821 |
|
|
|
(513 |
) |
|
|
285,308 |
|
Total liabilities |
|
|
369,141 |
|
|
|
(513 |
) |
|
|
368,628 |
|
Accumulated deficit |
|
|
(800,390 |
) |
|
|
(1,242 |
) |
|
|
(801,632 |
) |
Total shareholders’ deficit |
|
|
(22,397 |
) |
|
|
(1,242 |
) |
|
|
(23,639 |
) |
Total liabilities and shareholders’ deficit |
|
|
346,744 |
|
|
|
(1,755 |
) |
|
|
344,989 |
|
The effect of the adjustments on the line items within the Company’s consolidated statements of operations as of December 31, 2021 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses applicable to revenues (exclusive of depreciation and amortization expense) |
|
$ |
(91,735 |
) |
|
$ |
(1,755 |
) |
|
$ |
(93,490 |
) |
Gross profit |
|
|
111,283 |
|
|
|
(1,755 |
) |
|
|
109,528 |
|
Loss from operations |
|
|
(22,025 |
) |
|
|
(1,755 |
) |
|
|
(23,780 |
) |
Loss from operations before income tax |
|
|
(53,999 |
) |
|
|
(1,755 |
) |
|
|
(55,754 |
) |
Income tax expense |
|
|
22,249 |
|
|
|
(513 |
) |
|
|
21,736 |
|
Net loss |
|
|
(76,248 |
) |
|
|
(1,242 |
) |
|
|
(77,490 |
) |
Earnings per share |
|
|
(0.44 |
) |
|
|
(0.01 |
) |
|
|
(0.45 |
) |
The effect of the adjustments on the line items on the Company’s consolidated statement of cash flow for the year ended December 31, 2021 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(76,248 |
) |
|
$ |
(1,242 |
) |
|
$ |
(77,490 |
) |
Change in operating assets and liabilities |
|
|
16,594 |
|
|
|
1,242 |
|
|
|
17,836 |
|
The effect of the adjustments on the line items within the Company’s consolidated statements of changes in shareholders’ (deficit) equity for the year ended December 31, 2022 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated deficit – Balance January 1, 2022 |
|
$ |
(800,390 |
) |
|
$ |
(1,242 |
) |
|
$ |
(801,632 |
) |
Total shareholders’ deficit – Balance January 1, 2022 |
|
|
(22,397 |
) |
|
|
(1,242 |
) |
|
|
(23,639 |
) |
|
Summary of Effect Of The Adjsutment On The Line Items Within Inventories |
The effect of the adjustment on the line items within the Company’s inventories as of December 31, 2021 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
6,188 |
|
|
$ |
— |
|
|
$ |
6,188 |
|
|
|
|
5,641 |
|
|
|
215 |
|
|
|
5,856 |
|
|
|
|
11,219 |
|
|
|
(1,970 |
) |
|
|
9,249 |
|
|
|
|
7,399 |
|
|
|
— |
|
|
|
7,399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|